CYP cynata therapeutics limited

Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT, page-12

  1. 8,719 Posts.
    lightbulb Created with Sketch. 1455
    Yeah, right.

    So who will be doing the Europe part?

    You might be blowing smoke up your own backside.

    Lacking resources and expertise to do trials. That's not extrapolating.

    A$6 Million for the whole lot? Wowsers.

    Well, CYP has entered into the 'advance stages of starting', so any moment now. It's really getting exciting now.

    Super Duper close now.

    Pure coincidence that the FDA P2 Trial for GVHD hasn't started before final news on MSB's FDA P3 approach?





    Final advanced stages of starting in the next few weeks/months.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
15.5¢
Change
-0.005(3.13%)
Mkt cap ! $35.02M
Open High Low Value Volume
16.0¢ 16.5¢ 15.5¢ $22.43K 139.5K

Buyers (Bids)

No. Vol. Price($)
4 58708 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 9763 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.